ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02091960
Brief Title: A Study to Assess the Efficacy and Safety of Enzalutamide With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2 Positive (HER2+), Androgen Receptor Positive (AR+) Metastatic or Locally Advanced Breast Cancer

First Submitted : March 18, 2014
First Submitted that Met QC Criteria : March 18, 2014
First Posted : March 19, 2014 (Estimate)

Results First Submitted : February 27, 2018
Results First Submitted that Met QC Criteria : April 18, 2018
Results First Posted : May 16, 2018

Last Update Submitted that Met QC Criteria : September 18, 2018
Last Update Posted : October 17, 2018